NCT04976426Not yet recruiting
Establishment and Clinical Validation of a New Technique for Early Diagnosis of Diabetic Nephropathy
Source: ClinicalTrials.gov · Last updated 26 Jul 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Diabetic kidney disease(DKD) is a leading cause of chronic kidney disease and end-stage renal disease across the world. Early identification of DKD is vitally important for the effective prevention and control of it. However, the available indicators are doubtful in the early diagnosis of DKD. This study aims to develop a novel system of multidimensional network biomarkers (MDNBs) to estimating early diabetic nephropathy, and further validating the performance of the novel systemin in prediction of the risk for early diabetic nephropathy by a nested case-control study.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 24 Jun 2021
- Start date
- 1 Jan 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Chronic kidney disease
- NCT number
- NCT04976426
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jan 2022 to the primary completion date, 31 Dec 2023
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Drug users or drug abusers;
Other illness
- Renal diseases caused by other causes, including primary and secondary;
- All kinds of acute infections;
- The expected life expectancy (life expectancy or related diseases) was less than 5 years according to the researcher's judgment.
- Sexually transmitted diseases such as viral hepatitis, AIDS and syphilis, and infectious diseases such as tuberculosis are in an active period;
Other
- Any situation judged by the researcher that affects enrollment.
Who the study is looking for
- Subjects who have signed informed consent.
- Subjects who were diagnosed with diabetes at least 5 years.
- Subjects showed good compliance, and the follow-up data was available for \>5 years.
Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.